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Identifying Regional Variation in the Prevalence of
Postpartum Haemorrhage: A Systematic Review and
Meta-Analysis
Clara Calvert*, Sara L. Thomas, Carine Ronsmans, Karen S. Wagner, Alma J. Adler, Veronique Filippi
London School of Hygiene and Tropical Medicine, London, United Kingdom
Abstract
Objective: To provide regional estimates of the prevalence of maternal haemorrhage and explore the effect of
methodological differences between studies on any observed regional variation.
Methods: We conducted a systematic review of the prevalence of maternal haemorrhage, defined as blood loss greater
than or equal to 1) 500 ml or 2) 1000 ml in the antepartum, intrapartum or postpartum period. We obtained regional
estimates of the prevalence of maternal and severe maternal haemorrhage by conducting meta-analyses and used meta-
regression to explore potential sources of between-study heterogeneity.
Findings: No studies reported the prevalence of antepartum haemorrhage (APH) according to our definitions. The
prevalence of postpartum haemorrhage (PPH) (blood loss $500 ml) ranged from 7.2% in Oceania to 25.7% in Africa. The
prevalence of severe PPH (blood loss $1000 ml) was highest in Africa at 5.1% and lowest in Asia at 1.9%. There was strong
evidence of between-study heterogeneity in the prevalence of PPH and severe PPH in most regions. Meta-regression
analyses suggested that region and method of measurement of blood loss influenced prevalence estimates for both PPH
and severe PPH. The regional patterns changed after adjusting for the other predictors of PPH indicating that, compared
with European women, Asian women have a lower prevalence of PPH.
Conclusions: We found evidence that Asian women have a very low prevalence of PPH compared with women in Europe.
However, more reliable estimates will only be obtained with the standardisation of the measurement of PPH so that the
data from different regions are comparable.
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Introduction
Haemorrhage is a leading cause of maternal death worldwide,
accounting for over 30% of maternal deaths in Africa and Asia [1].
Furthermore, it is a substantial source of maternal morbidity and
can have long-term effects on a woman’s health [2]. Untreated
maternal haemorrhage is associated with adverse health con-
sequences such as renal failure and anaemia and may detrimen-
tally affect a woman’s psychological well-being [3,4]. In very
severe cases hysterectomy may be used to control the bleeding.
Maternal haemorrhage can occur in the antepartum, intrapar-
tum or postpartum period. The WHO defines postpartum
haemorrhage (PPH) as blood loss of 500 ml or more from the
genital tract after delivery, although some studies define PPH as
blood loss greater than or equal to 1000 ml as this has greater
clinical significance [2]. Similar definitions do not exist for
antepartum haemorrhage (APH) or intrapartum haemorrhage
(IPH).
Several studies have attempted to estimate the global burden of
PPH. AbouZahr estimated severe PPH (blood loss $1000 ml) to
have a global prevalence of 10.5% amongst women who had a live
birth in the year 2000 [2]. In a systematic review of studies
published between 1997 and 2002, supplemented by a less
comprehensive search of the literature between 2003 and 2006,
Carroli et al. found a global prevalence of PPH $500 ml of 6.09%
and of PPH $1000 ml of 1.86%, much lower than AbouZahr’s
estimate [5]. This review also examined the prevalence of PPH by
region revealing marked differences. The prevalence of PPH
$500 ml ranged from 2.55% in Asia to 10.45% in Africa.
However, Carroli et al. found high between-study heterogeneity
within each region.
It is important to understand whether regional variation in
the prevalence of haemorrhage is likely to be due to true
variation and/or due to methodological differences between
studies. Factors that have been found to influence the measured
prevalence of maternal haemorrhage include the method of
blood loss measurement [6,7], management of the third stage of
labour [8] and whether the study is population-based or facility-
based [5].
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The aim of this review is to update the estimates of the global
burden of PPH, expand these estimates to include APH and IPH
and to examine whether similar patterns of regional variation
found by Carroli et al. are observed. Unlike previous studies, we
also examine potential sources of between-study heterogeneity
using meta-regression techniques.
Methods
This study was part of a wider systematic review of the burden
of maternal haemorrhage and the main causes of maternal
haemorrhage. A brief review protocol was developed and reviewed
by external experts. The primary outcome of interest for this study
was the prevalence of maternal haemorrhage, which includes
PPH, IPH and APH. Two definitions were used for maternal
haemorrhage: blood loss $500 ml or blood loss $1000 ml.
Search Strategy
Potentially relevant articles for the systematic review were
identified by searching bibliographical databases (Medline,
EMBASE, Popline, and CAB abstracts) and the WHO regional
databases (African Index Medicus, Eastern Mediterranean Re-
gion Index Medicus, Western Pacific Region Index Medicus and
Latin American and Caribbean Center on Health Sciences
Information). A full search strategy for each database was
developed using MeSH and free-text words for haemorrhage and
its causes and a more targeted search strategy comprised terms
for APH and IPH (Appendix 1). The search strategy aimed at
complementing the systematic review conducted by Carroli et al.
between 1997 and 2002. Because Carroli et al. only searched for
PPH studies, we screened all studies they included in the present
review, and added search terms for APH and IPH for the period
1997–2002. The full search strategy was applied to articles
published between 2003 and 2009, for which no previous review
was available. There were no language restrictions. Additional
publications were identified through manual searching of
reference lists from relevant articles.
Inclusion and Exclusion Criteria
Two authors (KW and CC) sequentially screened titles and
abstracts of identified citations for potential inclusion in the review
and full texts were sought for articles deemed to be relevant.
Studies were eligible for inclusion if they reported dates for data
collection, included data from 1990 onwards and had a sample
size of more than 30 pregnant women. Trials, cohort studies,
cross-sectional studies and population based case-control studies
were all eligible for inclusion. To ensure that studies were
representative of the population, hospital-based studies were only
included if the region in which the study was conducted had
$95% of births attended by a skilled birth attendant as identified
using Demographic and Health Surveys and data compiled by the
WHO [9]. Studies that relied on maternal self-reports of blood loss
were not included, as such reports do not provide valid estimates
of the prevalence of haemorrhage [10,11].
Analyses were conducted on studies which reported the
prevalence of maternal haemorrhage. Studies which only included
caesarean section births were excluded as in many settings only
a minority of births are delivered by caesarean sections, and such
studies could inflate estimates of PPH as caesarean sections
generally lead to higher blood loss.
Data Extraction
Data were extracted for each paper by a single author (KW, CC
or VF) on: location of study, study dates, study design, the study
population, mode and management of delivery, the case definition
of maternal haemorrhage, method of measurement of maternal
haemorrhage and the prevalence of maternal haemorrhage.
Information was also extracted on whether the study population
included all women or only women at low risk of PPH. The study
population was classified as at low risk of PPH if women with risk
factors for PPH, such as placenta praevia or PPH in a previous
delivery, were excluded. If more than one article provided data on
the same population and study period, data were extracted from
the article with the longest study duration. The intervention and
control arms of trials were extracted separately and treated as
separate datasets in the analysis.
Data Analysis
Analyses were carried out using R 2.12.2 and Stata 11.0. The
variance of each dataset’s prevalence was used to weight estimates
from each study to produce pooled estimates. To prevent the
prevalence of haemorrhage influencing the weight allocated to
each dataset, the prevalence from each dataset was transformed
using a Freeman-Tukey type arcsine square-root transformation
[12,13] and the variance was calculated as 1/(n+1). The I2 statistic
was calculated as a measure of the proportion of the overall
between-study variation in the prevalence of haemorrhage that
was due to differences between the studies and not chance [14].
The DerSimonian-Laird random effects method [15] was used to
combine study estimates. Estimates were stratified using regional
divides consistent with those used by Carroli et al. [5]: Africa, Asia
(including the Middle East), Europe, Northern America, Oceania
and Latin America and the Caribbean. Estimates were also
stratified by parity and by singleton or multiple births.
A meta-regression was conducted to identify sources of between-
study heterogeneity using Stata 11.0. The prevalence of PPH for
each study was transformed into an odds before conducting the
meta-regression. Five potential sources of heterogeneity, which
were specified a priori, were examined: region, mode of delivery
(vaginal/vaginal and caesarean deliveries), management of the
third stage of labour (active/mixed/unclear/expectant/unknown),
blood loss measurement method (objectively/subjectively/both/
unknown) and the study location (home and primary medical
centre/hospital/population). Studies were classified as using
objective measurement of blood loss if they used a calibrated
collection drape, a measuring jug or weighed blood soaked swabs
and linen. Studies were only considered as using active manage-
ment if they described using 1) a prophylactic uterotonic, including
misoprostol, 2) early cord clamping and cutting and 3) controlled
cord traction to deliver the placenta [16]. The unclear category
was for studies that described using one or two components of
active management but did not state whether the other
components of active management were used. To be classified
as population-based, the study had to include all women giving
birth, or a random sample of these women, from a well defined
geographical catchment population, for example a city or a region.
A multivariable meta-regression model was built by entering
region into the model initially. As any observed association
between region and prevalence of haemorrhage may be explained
by the other potential sources of heterogeneity, these were added
sequentially into the model starting with the variable which
showed the strongest association with prevalence of PPH on
univariable analysis; a variable remained in the multivariable
model if it was independently associated with the prevalence of
maternal haemorrhage at p#0.10.
Sensitivity analyses were conducted by restricting to only studies
which used objective methods for measuring blood loss.
The Global Prevalence of Postpartum Haemorrhage
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Results
We identified 13,205 potentially relevant articles and included
145 in the systematic review, of which 67 reported the prevalence
of maternal haemorrhage (Figure 1). An additional four eligible
articles were identified through manual searches of reference lists.
A total of 71 articles, providing 123 datasets were analysed
(references provided in File S1). No studies reported the
prevalence of APH as blood loss $500 ml or $1000 ml. We
classified all included studies as measuring PPH, although there
was variation in the timings of blood loss measurement. Whilst
many of the studies were restricted to blood loss after delivery,
three studies measured blood loss both during and after delivery
[17–19]; two of these studies stated that they were measuring PPH
[18,19]. Thirty-one studies stated that they measured PPH but did
not specify the timing of blood loss measurement (for example:
[20,21]). A further four studies referred to the outcome as ‘‘blood
loss’’ without stating specifically that they were measuring PPH or
specifying the timings of blood loss measurement [22–25], and two
studies measured blood loss at delivery [26,27].
Within the 123 datasets, 104 datasets defined PPH as blood loss
$500 ml; 39 were from Asia, 27 from Europe, 13 from Oceania,
ten from Northern America, nine from Latin America and the
Caribbean and six from Africa. Seventy datasets defined PPH as
blood loss $1000 ml; 28 were from Europe, 23 from Asia, seven
from Latin America and the Caribbean, six from Northern
America, four from Africa and two from Oceania. Fifty-one
datasets reported data for both definitions. Table 1 summarises the
characteristics of the datasets for each region. The proportion of
datasets which had a trial study design varied from 46.3% in
Oceania to 100% in Africa and the proportion with a sample size
.1000 women ranged from 0 in Africa to 55.5% in Latin America
and the Caribbean. Women were classified as at low risk of PPH in
27.3% of datasets in Latin America and the Caribbean with
increasing proportions up to 47.4% in Europe.
Prevalence of Postpartum Haemorrhage
The pooled prevalence of PPH $500 ml overall and stratified
by region, parity and singleton/multiple births is presented in
table 2, with individual prevalence estimates from the contrib-
uting studies outlined in supplementary Figures S1, S2, S3, S4,
S5, S6. Overall, 10.8% of women were estimated to suffer PPH
(95% CI: 9.6–12.1). However, there was wide regional variation
in PPH prevalence, ranging from 7.2% of women giving birth in
Oceania (95% CI: 6.3–8.1) to 25.7% in Africa (95% CI: 13.9–
39.7). Just over 8% of women giving birth were estimated to
suffer from PPH $500 ml in both Latin America and Asia and
prevalence was approximately 13% in Europe and in Northern
America. Within all regions there was strong evidence for
between-study heterogeneity (I2.95%, p,0.001). Further break-
down of the regional estimates of PPH $500 ml are provided in
Supplementary Table S1.
Figure 1. Study selection for inclusion in the systematic review and meta-analysis.
doi:10.1371/journal.pone.0041114.g001
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Women who had multiple births had a higher prevalence of PPH
$500 ml comparedwithwomenwho had singleton births, at 32.4%
(95% CI: 11.7–57.7) vs. 10.6% (95% CI: 8.6–12.7) respectively
(Table 1).Womenwhowere having their first baby had a prevalence
of PPHof 12.9% (95%CI: 9.1–17.4) comparedwith 10.0%amongst
women who were multiparous (95% CI: 6.4–14.3).
Prevalence of Severe Postpartum Haemorrhage
Whilst the overall prevalence of severe PPH $1000 ml, was
much lower (2.8%, 95% CI: 2.4–3.2) than the prevalence of PPH,
similar regional patterns were observed (Table 3 and Supplemen-
tary Figures S7, S8, S9, S10, S11, S12). Africa had the highest
prevalence of severe PPH at 5.1% (95% CI: 0.3–15.3), followed by
a prevalence of 4.3% in Northern America, with the lowest
prevalence in Asia at 1.9%. Around 3% of women giving birth in
Latin America, Europe and Oceania were estimated to suffer
severe PPH. There was strong evidence for between-study
heterogeneity within most regions (p,0.001), but not for the six
Northern American studies (I2 = 2.2%, p= 0.4) and the two
Oceania studies (I2 = 0%, p,0.68). Sub-regional estimates of PPH
$1000 ml are presented in Supplementary Table S2.
When severe PPH $1000 ml was stratified singleton/multiple
deliveries very similar patterns to PPH $500 ml were observed
(Table 2). Severe PPH was higher for multiple births (5.7%, 95%
CI: 1.5–12.4) compared with singleton births (2.8%, 95% CI: 1.9–
3.6). However a different pattern was observed for parity, whereby
multiparous women has a higher prevalence of severe PPH (9.6%,
95% CI: 0–39.3) compared with women giving birth for the first
time (5.3%, 95% CI: 2.3–3.7).
Sources of Heterogeneity
In the univariate meta-regression there was evidence that region
(p = 0.01), blood loss measurement method (p,0.001), type of
management of deliveries (p = 0.002), mode of delivery (p = 0.05)
and study location (p = 0.03) influenced the between-study
variation in the prevalence of PPH of blood loss $500 ml
(Table 4). In the multivariable meta-regression model, region
(p = 0.03), method of measurement of blood loss (p,0.001) and, to
some extent, management of delivery (p = 0.10) remained in-
dependently associated with prevalence. Together these three
predictors explained 30% of the between-study heterogeneity.
Studies where expectant management of deliveries was used had,
on average, a higher prevalence of PPH compared with studies
that used active management of labour. Studies that used
subjective measurement of blood loss and those not stating how
blood loss was measured had, on average, a lower prevalence of
PPH than studies using objective measurements. Introducing
measurement of blood loss and management of delivery into the
Table 1. Description of datasets in each region.
Africa
Latin America
and Caribbean
Northern
America Asia Europe Oceania
Total number of datasets 6 11 12 43 38 13
Study characteristics
Study design Observational 0 (0) 2 (18.2) 4 (33.3) 10 (23.3) 17 (44.7) 7 (53.8)
Trial 6 (100) 9 (81.8) 8 (66.7) 33 (76.7) 21 (55.3) 6 (46.2)
Sample Size #1000 6 (100) 5 (45.5) 9 (75.0) 34 (79.1) 20 (52.6) 6 (46.2)
.1000 0 (0) 6 (55.5) 3 (25.0) 9 (20.9) 18 (47.4) 7 (53.8)
Method of measurement of
blood loss
Objectively 4 (66.7) 6 (54.6) 0 (0) 29 (67.4) 12 (31.6) 0 (0)
Subjectively 2 (33.3) 4 (36.4) 12 (100.0) 7 (16.3) 9 (23.7) 5 (38.5)
Both 0 (0) 0 (0) 0 (0) 2 (4.7) 5 (13.2) 2 (15.4)
Unknown 0 (0) 1 (9.1) 0 (0) 5 (11.6) 12 (31.6) 6 (46.2)
Study location Population 0 (0) 2 (18.2) 1 (8.3) 1 (2.3) 6 (15.8) 5 (38.5)
Hospital 0 (0) 9 (81.8) 9 (75.0) 40 (93.0) 29 (76.3) 6 (46.2)
Primary medical centre/
home
6 100.0) 0 (0) 2 (16.7) 2 (4.7) 3 (7.9) 2 (15.4)
Characteristics of Women
Study population All women 4 (66.7) 8 (72.7) 5 (41.7) 24 (55.8) 20 (52.6) 9 (69.2)
Low PPH risk 2 (33.3) 3 (27.3) 7 (58.3) 19 (44.2) 18 (47.4) 4 (30.8)
Include multiple gestation Yes 2 (33.3) 1 (9.1) 2 (16.7) 0 (0) 3 (7.9) 4 (30.7)
No 0 (0) 8 (72.7) 7 (58.3) 25 (58.1) 18 (47.4) 5 (38.5)
Not specified 4 (66.7) 2 (18.2) 3 (25.0) 18 (41.9) 17 (44.7) 4 (30.8)
Management of delivery
Active 0 (0) 4 (36.4) 6 (50.0) 23 (53.5) 17 (34.0) 0 (0)
Mixed 4 (66.7) 2 (18.2) 0 (0) 2 (4.7) 2 (20.0) 0 (0)
Unclear1 0 (0) 1 (9.1) 3 (25.0) 9 (20.9) 2 (20.0) 2 (15.4)
Expectant 2 (33.3) 0 (0) 0 (0) 1 (2.3) 3 (7.9) 0 (0)
Unknown 0 (0) 4 (36.4) 3 (25.0) 8 (18.6) 14 (36.8) 11 (84.6)
doi:10.1371/journal.pone.0041114.t001
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model with region reduced the strength of the association between
region and prevalence of PPH. In this multivariable model, we
found that compared with Europe, studies conducted in Asia have,
on average, a lower prevalence of PPH. Mode of delivery was not
included in the final model as it was strongly correlated with
management of delivery (correlation coefficient = 0.60, p,0.001)
and showed less strong evidence for an association with PPH than
management of delivery. In addition, eight of the nine ‘‘mixed’’
delivery studies did not specify how delivery was managed, and
consequently the ‘‘unknown’’ management of delivery category
captures the effect of studies which included both vaginal and
caesarean deliveries.
There was evidence, in univariate analyses, that variation in the
prevalence of severe PPH between studies was associated with
mode of delivery (p = 0.08) and blood loss measurement method
(p = 0.001), but not with region (p = 0.47) (Table 5). However, in
a multivariable model, region (p = 0.02) and blood loss measure-
ment method (p,0.001) were independently associated with
variation in prevalence of severe PPH, together explaining
29.4% of the between-study heterogeneity. After accounting for
measurement of blood loss, studies conducted in Asia had, on
average, a lower prevalence of severe PPH compared to studies
conducted in Europe and studies conducted in Northern America
had, on average, a higher prevalence.
The prevalence of PPH was higher when the meta-analysis was
restricted only to studies which used objective methods to measure
blood loss. For blood loss $500 ml the overall prevalence was
14.2% and for blood loss $1000 ml the prevalence was 4.2%. A
similar pattern was observed across the regions, as shown in
Table 2 and Table 3.
Discussion
Our systematic review estimates the global prevalence of PPH to
be 10.8% and of severe PPH to be 2.8%. These results are higher
than those estimated by Carroli et al [5], although, for severe PPH,
lower than AbouZahr’s estimate of 10.5% [2]. It is plausible that our
increased estimates of PPH prevalence compared to those of Carroli
et al. [5] is due to a genuine increase. A study by Knight et al. found
evidence for an increasing trend in PPH in Australia, Canada, the
UK and the USA between 1991 and 2006 [28]. The authors suggest
this increase could be due to rising obesity levels, changes in the
management of delivery and increasing tolerance to longer duration
of labour [28].We also found good evidence for regional variation in
the prevalence of PPH, although the only clear trendwhich emerged
after other predictors of blood loss were controlled for was
a particularly low prevalence in Asia. There were no clear regional
trends for severe PPH at the crude level, but the pattern changed
when adjusting for different blood lossmeasurementmethods. Asian
women had a very low prevalence of severe PPH compared to
European women, whilst North American women had the highest
prevalence.
It is possible that the lower prevalence of PPH observed
amongst the Asian studies is due to regional differences in genetics
or underlying risk factors. Obesity has been implicated as a risk
factor for PPH [29,30], and a substantially lower proportion of
women living in Asia are obese compared with European women
[31] possibly explaining some of the observed trend. Similarly, the
high prevalence of severe PPH observed in America may be due to
rising levels of obesity and higher maternal age in this region
[29,30].
Meta-regression techniques enabled us to examine the influence
of both methodological differences between studies and of the
clinical management of the deliveries on the prevalence of
haemorrhage. We found that blood loss measurement method
plays a critical role in the variation of reported prevalence of PPH
and severe PPH, with subjective measurement leading to lower
estimates of prevalence. Management of delivery was also
associated with prevalence of PPH, in line with trials which have
found that active management is protective against PPH [8].
However, such an association was not seen with the prevalence of
severe PPH, suggesting that certain causes of severe PPH may not
be amenable to prevention through active management of
delivery. Taking these predictors into account affected the
association between region and prevalence of both PPH and
severe PPH. Amongst studies reporting PPH, blood loss measure-
ment method and management of deliveries appeared to explain
some, but not all, of the regional variation. For those studies
reporting severe PPH, differences in blood loss measurement
method was masking some of the regional variation, and when
controlled for the association between prevalence of PPH and
region became stronger. Only about 30% of the between-study
heterogeneity was explained by both the final models suggesting
that there are other methodological and/or biological factors
explaining the remaining between-study heterogeneity. In order to
reduce the chance of identifying spurious associations, study
characteristics to be used in the meta-regression were specified
before conducting any analyses. However, the meta-regression
results still need to be interpreted with caution. The number of
studies in some categories, particularly for Africa and for severe
PPH, was small and this may have limited the power to detect
associations. Furthermore, studies frequently did not provide
adequate information on the explored sources of heterogeneity
and were classified as unknown for certain categories. As with any
study using observation data, these meta-regression analyses are
subject to residual confounding: any associations seen between
a study characteristic and the prevalence of PPH may actually
reflect a true association of another unmeasured study character-
istic which is correlated which the characteristic being investigat-
ed. Finally, the results of the meta-regression rely on the use of
study-level covariates which may or may not reflect the relation-
ship that would be observed if we had investigated the association
at the individual level.
We did not succeed in identifying any studies which defined
APH according to volume of blood loss. This is likely to be due to
the fact no universal definition exists for APH. APH results from
abortions, ectopic pregnancies, placenta praevia and abruptio
placentae; these causes can lead to a small amount of external
bleeding before labour or abortion. Placenta praevia and abruptio
placentae may also cause substantial bleeding during labour.
Although the WHO has defined PPH, many of the studies
included did not state when blood loss was measured and others
included intrapartum blood loss in the measurement of PPH.
Our review has other limitations. Firstly, for some regions there
were only a few studies that may not be representative of the
prevalence of PPH in the whole region. For example, none of the
three studies conducted in Africa came from the northern,
southern or middle regions of Africa. The African study conducted
by Hoj et al. [32] found an extremely high prevalence of PPH
which is unlikely to be representative of the whole continent.
Excluding this study would have lead to a much lower estimate of
the prevalence of haemorrhage in Africa. Similarly, in Asia the
studies generally come from more developed regions of East Asia,
such as Japan and Hong Kong, and the Middle East and these
studies are unlikely to be representative of the prevalence in less
economically developed counties. Secondly, there were few
population based studies, with most of the studies conducted in
single hospitals. Finally, there was very high between-study
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heterogeneity within each region and each summary regional
estimate obtained from the meta-analysis is an average of within-
region prevalences which are genuinely different from one
another.
This work highlights the complexities in producing regional
estimates of the prevalence of PPH, and calls into question
whether we should be combining studies which are so method-
ologically varied to give one summary estimate. However,
obtaining better estimates remains an important endeavour.
Accurate measurements of the frequency of events such as PPH,
an important cause of maternal mortality, enable assessment of
progress in improving clinical practice and maternal and neonatal
health outcomes. Obtaining these measurements will require
increased awareness from clinicians and public health practitioners
about the importance of maintaining clinical records with accurate
and replicable information, and standardisation of methodologies
such as the method and timing of blood loss measurement for
PPH. In particular, we strongly recommend that researchers use
objective methods for measuring blood loss, as opposed to visual
estimation, as results from our sensitivity analysis suggest that use
of non-objective methods may underestimate blood loss due to
imprecise measurement. The scarcity of population representative
data from developing countries highlights the need for better
methods of capturing a random sample of the whole population in
such areas, ultimately by capturing both births occurring within
homes and facilities. Only when such data become available will
we be able to provide accurate estimates of the global burden of
maternal haemorrhage and ascertain whether there is true
regional variation in PPH due to differences in clinical practice
rather than apparent differences due to heterogeneity in the
quality of studies conducted in each region.
Supporting Information
Figure S1 Forest plot of prevalence of PPH$500 ml
amongst studies conducted in Africa.
(TIFF)
Figure S2 Forest plot of prevalence of PPH$500 ml
amongst studies conducted in Latin America and the
Caribbean.
(TIFF)
Figure S3 Forest plot of prevalence of PPH$500 ml
amongst studies conducted in Northern America.
(TIFF)
Figure S4 Forest plot of prevalence of PPH$500 ml
amongst studies conducted in Asia.
(TIFF)
Figure S5 Forest plot of prevalence of PPH$500 ml
amongst studies conducted in Europe.
(TIFF)
Figure S6 Forest plot of prevalence of PPH$500 ml
amongst studies conducted in Oceania.
Table 5. Meta-regression for PPH $1000 ml.
No. of datasets1
(n =69)
Prevalence of
haemorrhage (%) Univariable
Multivariable model (29.4% of
variation explained)
OR (95% CI) P-value AOR2,3 (95% CI) P-value
Region Europe 27 2.8 (2.3–3.4) 1 1
Africa 4 5.1 (0.3–15.3) 1.16 (0.36–3.70) 0.59 (0.22–1.64)
Latin America 7 3.3 (1.8–5.2) 1.29 (0.51–3.22) 0.96 (0.43–2.13)
N. America 6 4.3 (3.9–4.7) 1.40 (0.53–3.73) 2.70 (1.06–6.85)
Asia 23 1.9 (1.2–2.8) 0.64 (0.35–1.18) 0.52 (0.30–0.88)
Oceania 2 3.0 (1.4–5.1) 1.20 (0.25–5.88) 0.47 0.97 (0.22–4.33) 0.02
Mode of delivery Mixed 8 1.4 (0.6–2.5) 1 – –
Vaginal 61 3.1 (2.5–3.9) 2.05 (0.92–4.55) 0.08 – –
Management of deliveries Active 33 2.8 (2.1–3.6) 1 – –
Mixed 8 4.8 (1.8–9.3) 1.51 (0.65–3.50) – –
Unclear 15 1.9 (0.8–3.2) 0.70 (0.36–1.36) – –
Expectant 3 5.6 (2.1–10.6) 2.27 (0.62–8.21) – –
Unknown 10 2.5 (1.4–3.9) 0.73 (0.34–1.57) 0.26 – –
Method of measurement
of blood loss
Objectively 35 4.2 (3.2–5.3) 1 1
Subjectively 20 1.7 (1.0–2.6) 0.41 (0.24–0.70) 0.27 (0.15–0.48)
Both 8 2.7 (1.4–4.4) 0.74 (0.34–1.59) 0.63 (0.28–1.44)
Unknown 6 0.7 (0.5–0.9) 0.24 (0.10–0.57) 0.001 0.19 (0.08–0.44) ,0.001
Study location Population 3 2.1 (0.2–5.7) 1 – –
Hospital 8 2.7 (2.2–3.3) 1.29 (0.35–4.68) – –
Primary medical
centre/home
58 4.1 (1.1–9.1) 1.53 (0.35–6.71) 0.84 – –
1One dataset excluded from meta-regression as it was unclear whether it only included vaginal deliveries or whether caesarean deliveries were also included.
2AOR=Adjusted odds ratio.
3Adjusted for region and method of measurement of blood loss.
doi:10.1371/journal.pone.0041114.t005
The Global Prevalence of Postpartum Haemorrhage
PLoS ONE | www.plosone.org 9 July 2012 | Volume 7 | Issue 7 | e41114
(TIFF)
Figure S7 Forest plot of prevalence of PPH$1000 ml
amongst studies conducted in Africa.
(TIFF)
Figure S8 Forest plot of prevalence of PPH$1000 ml
amongst studies conducted in Latin America and the
Caribbean.
(TIFF)
Figure S9 Forest plot of prevalence of PPH$1000 ml
amongst studies conducted in Northern America.
(TIFF)
Figure S10 Forest plot of prevalence of PPH$1000 ml
amongst studies conducted in Asia.
(TIFF)
Figure S11 Forest plot of prevalence of PPH$1000 ml
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